Get Your Personalized Supplement StackSupplement Stack Quiz

Sodium Hyaluronic Acid

Also known as: NaHA, Hyaluronan, hyaluronic acid sodium salt, hyaluronic acid, Sodium Hyaluronate

Overview

Sodium Hyaluronate (NaHA) is the sodium salt of hyaluronic acid (HA), a high molecular-weight polysaccharide naturally occurring in connective tissues and synovial fluid. It is composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. NaHA functions as a lubricant and shock absorber within the body. It is widely used as an oral supplement and via intra-articular injection, primarily for managing joint disorders like osteoarthritis (OA) and alleviating knee discomfort. Additionally, it finds applications in dermatology for skin hydration and wound healing. While research on intra-articular use, particularly for OA, is extensive with numerous randomized controlled trials and meta-analyses, studies on oral supplementation are fewer but are steadily increasing, showing promising results.

Benefits

Oral sodium hyaluronate has demonstrated benefits in reducing joint discomfort. A 12-week randomized controlled trial involving healthy adults reported significant reductions in knee pain, stiffness, and overall discomfort, as measured by a visual analog scale (VAS), compared to a placebo. A systematic review of 11 studies on oral HA for osteoarthritis and low back pain found that 9 of these studies reported improvements in pain (VAS), joint function (WOMAC), and stiffness, with a low incidence of mild adverse effects. For intra-articular sodium hyaluronate, meta-analyses indicate it is generally safe, with local, non-serious adverse events being more common than with saline injections, but no significant difference in serious adverse events. Furthermore, combining arthroscopic surgery with intra-articular sodium hyaluronate injections has been shown to improve clinical outcomes in knee osteoarthritis more effectively than surgery alone.

How it works

Sodium hyaluronate primarily works by enhancing the viscosity and elasticity of synovial fluid, thereby improving joint lubrication and shock absorption within the joint capsule. It is also believed to modulate inflammatory cytokines, which contributes to reducing joint inflammation and pain. While the exact mechanism of oral absorption is still debated, evidence suggests that lower molecular weight fractions of HA may be absorbed systemically, potentially exerting effects on connective tissues throughout the body. Intra-articular injections deliver HA directly into the joint space, effectively restoring the natural properties of synovial fluid and potentially stimulating the body's own production of hyaluronic acid.

Side effects

Oral sodium hyaluronate is generally considered safe, with clinical trials reporting only rare and mild adverse effects. For intra-articular injections, the most common adverse events are local and non-serious, such as pain or swelling at the injection site, which typically resolve within a few days. Meta-analyses have not identified any significant systemic adverse effects or serious adverse events associated with either oral or intra-articular administration. No major drug interactions or contraindications have been identified in the reviewed studies. Patients should be aware of the potential for temporary local discomfort following injections, but these are usually transient and not indicative of a serious issue. Overall, both forms of administration have a favorable safety profile.

Dosage

Oral sodium hyaluronate dosages in studies have ranged from 30 mg to 300 mg per day, with observed benefits across this spectrum over treatment periods lasting from 4 weeks to 12 months. The optimal oral dosage is not yet fully established, but efficacy has been noted with 12-week supplementation in healthy adults. For intra-articular injections, the number of injections per treatment series typically varies from 1 to 5, depending on the specific product and clinical protocol. Oral supplementation generally requires several weeks to months for effects to become noticeable, indicating a need for consistent, long-term use. In contrast, intra-articular injections often provide more immediate symptom relief due to direct delivery to the affected joint.

FAQs

Is oral sodium hyaluronate effective for joint pain?

Yes, evidence suggests oral sodium hyaluronate can lead to modest improvements in knee discomfort and osteoarthritis symptoms after several weeks of consistent supplementation.

Are injections safer or more effective than oral supplements?

Intra-articular injections have stronger evidence for significant osteoarthritis symptom relief but carry local injection risks. Oral forms are safer with less robust, but emerging, evidence.

How soon do effects appear with sodium hyaluronate?

Effects from oral supplementation typically appear after several weeks to months of consistent use. Intra-articular injections may provide faster symptom relief due to direct delivery.

Can sodium hyaluronate be used long-term?

Studies up to 12 months have shown safety for both oral and intra-articular use. While long-term safety data are limited beyond this, no major concerns have been reported.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC10792404/ – This randomized, double-blind, placebo-controlled trial (n=31 healthy adults) over 12 weeks demonstrated a significant reduction in knee pain and stiffness with oral sodium hyaluronate (p<0.05) compared to placebo, with no significant adverse effects. The study supports the efficacy of oral NaHA for improving knee discomfort in healthy individuals.
https://journals.sagepub.com/doi/10.1177/1947603519888783 – This systematic review and meta-analysis assessed the safety of intra-articular HA in knee OA across multiple RCTs. It found no significant increase in serious adverse events compared to saline injections, though local adverse events were more frequent but mild (RR=1.21, p=0.003). The study concludes that intra-articular HA is generally safe for knee OA.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11778613/ – This systematic review of 11 studies (n=597 patients with OA or low back pain) on oral HA reported that 9 out of 11 studies showed significant improvements in pain and function. Doses ranged from 30-300 mg/day over 4 weeks to 12 months, with rare and mild adverse effects, indicating promising efficacy and safety for oral HA in joint conditions.
https://apm.amegroups.org/article/view/78815/html – This meta-analysis compared arthroscopy plus intra-articular sodium hyaluronate versus arthroscopy alone in knee OA. It concluded that combination therapy led to improved clinical outcomes, suggesting a synergistic benefit of adding HA injections to surgical intervention for knee osteoarthritis.